Bharat Biotech's Covaxin effective on UK strain of Covid-19: ICMR

In phase II clinical trial, the vaccine candidate showed noteworthy results with plaque reduction neutralization test

An Indian Council of Medical Research (ICMR) study on Covaxin shows a comparable neutralization activity of the vaccinated individuals against UK-variant strain.

The ICMR's National Institute of Virology scientist performed the plaque reduction neutralization test using sera collected from the 26 recipients of Bharat Biotech's coronavirus vaccine (COVAXIN) against UK-variant strain.

"A comparable neutralization activity of the vaccinated individuals sera showed against UK-variant and the heterologous strain with similar efficiency dispel the uncertainty of possible neutralization escape," stated document appeared in bioRxiv in a pre-print version.

"We successfully isolated and characterized the SARS-CoV-2 from UK returnees in India with all signature mutations of